Abstract:Schistosomiasis, a disease caused by blood flukes of the genus <em>Schistosoma</em>, belongs to the neglected tropical diseases. Left untreated, schistosomiasis can lead to severe health problems and even death. An estimated 800 million people are at risk of schistosomiasis and 250 million people are infected. The global strategy to control and eliminate schistosomiasis emphasizes large-scale preventive chemotherapy with praziquantel targeting school-age children. Other tools are available, such as information, education, and communication (IEC), improved access to water, sanitation, and hygiene (WASH), and snail control. Despite available evidence of the effectiveness of these control measures, analyses estimating the most cost-effective control or elimination strategies are scarce, inaccurate, and lack standardization. We systematically reviewed the literature on costs related to public health interventions against schistosomiasis to strengthen the current evidence-base.In adherence to the PRISMA guidelines, we systematically searched three readily available electronic databases (i.e., PubMed, WHOLIS, and ISI Web of Science) from inception to April 2019 with no language restrictions. Relevant documents were screened, duplicates eliminated, specific rules on studies to consider were defined, and the eligible studies fully reviewed. Costs of schistosomiasis interventions were classified in three groups: (i) preventive chemotherapy; (ii) preventive chemotherapy plus an individual diagnostic test to identify at-risk population; and (iii) test-and-treat interventions.Fifteen articles met our inclusion criteria. In general, it was hard to compare the reported costs from the different studies due to different approaches used to estimate and classify the costs of the intervention assessed. Costs varied considerably from one study to another, ranging from US$ 0.06 to US$ 4.46 per person treated. The difference between financial and opportunity costs only played a minimal role in the explanation of the costs' variation, even if delivery costs were two times higher in the analyses including economic costs. Most of the studies identified in our systematic review focused on sub-Saharan African countries.The degree of transparency of most of the costing studies of schistosomiasis interventions found in the current review was limited. Hence, there is a pressing need for strategies to improve the quality of cost analyses, and higher reporting standards and transparency that should be fostered by peer-review journal policies. Cost information on these interventions is crucial to inform resource allocation decisions and those regarding the affordability of scaling-up interventions.Schistosomiasis is one of about 20 neglected tropical diseases. It affects millions of people mainly in poor settings in African countries. The global strategy to control and eliminate schistosomiasis emphasizes large-scale preventive chemotherapy with praziquantel targeting school-age children. Evidence of the effectiveness of these control measures is largely available, while less is known about the costs of their implementation. We systematically reviewed the literature and analyzed studies that estimated costs of schistosomiasis interventions. We summarized the available evidence in three intervention groups: (i) preventive chemotherapy; (ii) preventive chemotherapy plus an individual diagnostic test to identify at-risk population; and (iii) test-and-treat interventions. Costs were overall hard to compare and varied considerably from one study to another. There is a need for higher reporting standards and transparency that should be fostered by peer-review journal policies. Cost information on these interventions is crucial to inform resource allocation decisions and those regarding the affordability of scaling-up interventions.

A systematic review of Schistosoma intercalatum: an obscure causative agent of human schistosomiasis

A systematic literature review of schistosomiasis in urban and peri-urban settings

A comprehensive exploration of schistosomiasis: Global impact, molecular characterization, drug discovery, artificial intelligence and future prospects

Schistosomiasis–Microbiota Interactions: A Systematic Review and Meta-Analysis

Population genetics of African Schistosoma species

Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review

Prevalence and correlations of schistosomiasis mansoni and schistosomiasis haematobium among humans and intermediate snail hosts: a systematic review and meta-analysis

Current Status of Urinary Schistosomiasis Among Communities in Kurmuk District, Western Ethiopia: Prevalence and Intensity of Infection

Beyond schistosomiasis: unraveling co-infections and altered immunity

A retrospective analysis of schistosomiasis related literature from 2011-2020: Focusing on the next decade

A Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis

Cost of interventions to control schistosomiasis: A systematic review of the literature

Asian Schistosomiasis: Current Status and Prospects for Control Leading to Elimination

Prevalence of human schistosomiasis in various regions of Tanzania Mainland and Zanzibar: A systematic review and meta-analysis of studies conducted for the past ten years (2013–2023)

Knowledge and perceptions of schistosomiasis, a water-borne disease, in two semi-arid rural areas of South Africa (Ndumo) and Zimbabwe (Ntalale)

Detecting and identifying Schistosoma infections in snails and aquatic habitats: A systematic review

A critical review of the limitations of current diagnostic techniques for schistosomiasis

Molecular epidemiology and population genetics of Schistosoma mansoni infecting school-aged children situated along the southern shoreline of Lake Malawi, Malawi

African Schistosomiasis: A Framework of Indicators Assessing the Transmission Risk and Intervention Effectiveness

Schistosomiasis Japonica: Control and Research Needs

Have there been efforts to integrate malaria and schistosomiasis prevention and control programs? A scoping review of the literature